Literature DB >> 20653993

Epigenetic studies in human diseases.

J Halusková1.   

Abstract

Irreversible genetic alterations underlying human diseases have been widely studied to date. However, it is evident that the potentially reversible epigenetic dysregulations may also have an important role in the disease origin. The studies of epigenetic mechanisms underlying disease onset, progression and pathogenesis have been performed in various human disorders. The epigenetic approaches may reveal useful markers for disease diagnostics, classification and prognostics as well as for progressive pharmacological treatment. This review summarizes the studies of epigenetic dysregulations including aberrant methylation, histone modifications and miRNA alterations in cancer as well as the studies of methylation changes and aberrant histone modifications in neurodegenerative, autoimmune, cardiovascular and other diseases. The imprinting disorders together with the emerging role of epigenetics in nutritional genomics, environment-organism interaction studies and in some other fields are also mentioned.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20653993

Source DB:  PubMed          Journal:  Folia Biol (Praha)        ISSN: 0015-5500            Impact factor:   0.906


  23 in total

1.  A novel method for detecting 7-methyl guanine reveals aberrant methylation levels in Huntington disease.

Authors:  Beena Thomas; Samantha Matson; Vanita Chopra; Liping Sun; Swati Sharma; Steven Hersch; H Diana Rosas; Clemens Scherzer; Robert Ferrante; Wayne Matson
Journal:  Anal Biochem       Date:  2013-02-12       Impact factor: 3.365

2.  A genome-wide DNA methylation analysis in peripheral blood from patients identifies risk loci associated with Graves' orbitopathy.

Authors:  Z Xin; L Hua; T-T Shi; X Tuo; F-Y Yang; Y Li; X Cao; J-K Yang
Journal:  J Endocrinol Invest       Date:  2017-11-30       Impact factor: 4.256

Review 3.  Effects of arsenic toxicity beyond epigenetic modifications.

Authors:  Geir Bjørklund; Jan Aaseth; Salvatore Chirumbolo; Mauricio A Urbina; Riaz Uddin
Journal:  Environ Geochem Health       Date:  2017-05-08       Impact factor: 4.609

Review 4.  Prediction of preeclampsia-bench to bedside.

Authors:  Anjali Acharya; Wunnie Brima; Shivakanth Burugu; Tanvi Rege
Journal:  Curr Hypertens Rep       Date:  2014-11       Impact factor: 5.369

5.  Epigenetics and microRNAs in preeclampsia.

Authors:  Mahua Choudhury; Jacob E Friedman
Journal:  Clin Exp Hypertens       Date:  2012-04-02       Impact factor: 1.749

Review 6.  Potential value of nutrigenomics in Crohn's disease.

Authors:  Lynnette R Ferguson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-03-13       Impact factor: 46.802

7.  Tinkering with transcription factors uncovers plasticity of somatic cells.

Authors:  Judi L Azevedo; Ricardo A Feldman
Journal:  Genes Cancer       Date:  2010-11

8.  Association of polymorphisms in DNMT1, DNMT3A, DNMT3B, MTHFR and MTRR genes with global DNA methylation levels and prognosis of autoimmune thyroid disease.

Authors:  Y Arakawa; M Watanabe; N Inoue; M Sarumaru; Y Hidaka; Y Iwatani
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

9.  Long-term health consequences of prenatal arsenic exposure: links to the genome and the epigenome.

Authors:  Kathryn Bailey; Rebecca C Fry
Journal:  Rev Environ Health       Date:  2014       Impact factor: 3.458

10.  Arsenic and the epigenome: interindividual differences in arsenic metabolism related to distinct patterns of DNA methylation.

Authors:  Kathryn A Bailey; Michael C Wu; William O Ward; Lisa Smeester; Julia E Rager; Gonzalo García-Vargas; Luz-Maria Del Razo; Zuzana Drobná; Miroslav Stýblo; Rebecca C Fry
Journal:  J Biochem Mol Toxicol       Date:  2013-01-11       Impact factor: 3.642

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.